34 research outputs found

    Overactive bladder – 18 years – Part II

    Full text link

    Comparison of initial efficacy and long-term follow-up of heparin-coated Jostent with conventional NIR stent.

    No full text
    The implantation of heparin-coated stents was reported to be well tolerated, but there are conflicting results about acute in-hospital complications. (sub)acute thrombosis rates, and long-term follow-up compared to uncoated stents. We compared the angiographic and clinical results after coronary placement of two stent models: the heparin-coated premounted Jostent and the uncoated premounted NIR stent. Of 710 patients revascularized, a total of 426 patients received Jostent (n = 230) or NIR stent (n = 196) implantation. The primary end points were acute or subacute thrombosis, urgent CABG, AMI or death, while the secondary end points were the comparison of the restenosis rates of the stents at the 6th month and of the functional angina classification of the stent groups at the 1st, 6th and 12th months. There were no significant differences between the Jostent and NIR stent groups regarding angiographic and procedural success. Acute thrombosis rates in the Jostent and NIR stent groups were similar while no subacute thrombosis was observed in either group. The major adverse cardiac event rates of the groups also did not differ. Angiographic restenosis occurred in 17% of the Jostent group and 16% of the NIR stent group (NS). The combined clinical and angiographic restenosis rate was also similar between the Jo and NIR groups (19% and 18%, respectively). Comparison of functional angina classes at the 1st, 6th and 12th months revealed no significant difference between the study groups. In conclusion, when compared with implantation of an uncoated premounted NIR stent, implantation of a heparin-coated premounted Jostent does not provide any more benefit with respect to initial efficacy, sub(acute) thrombosis and 6-month restenosis rates and 12-month clinical outcomes

    Jostent with conventional NIR stent

    Get PDF
    The implantation of heparin-coated stents was reported to be well tolerated. but (here are conflicting, results about acute in-hospital complications, (sub)acute thrombosis rates and long-term fallow-up compared to uncoated stents. We compared the angiographic and clinical results after coronary placement of two stent models: the heparin-coated pre-mounted Jostent and the uncoated premounted NIR stent. Of 7 10 patients revascularized, a total of 426 patients received Jostent (n = 230) or NIR stent (11 = 196) implantation. The primary end points were acute or subacute thrombosis. UF2ent CABG. AMI or death. while the secondary end points were the comparison of the restenosis rates of the stents at the 6(th) month and of the functional angina classification of the Stein groups at the 1(st) 6(th) and 12(th) months. There were no Significant differences between (lie Jostent and NIR stent groups regarding angiographic and procedural success. Acute thrombosis rates in the Jostent and NIR stent groups were similar while no subacute thrombosis was observed in either group. The major adverse cardiac event rates of the groups also did not differ. Angiographic restenosis occurred in 17% of the Jostent group and 16% of (lie NIR stent groups (NS). The combined clinical and angiographic restenosis rate was also Similar between the Jo and NIR groups (19% and 18%. respectively). Comparison of functional angina classes at the 1 6(th) and 12(th) months revealed no significant difference between the study groups.In conclusion, when compared with implantation of all uncoated premounted NIR Stent, implantation of a heparin-coated premounted Jostent does not provide any more benefit with respect to initial efficacy., sub(acute) thrombosis and 6-month restenosis rates and 12-month clinical outcomes

    Atomic force microscope tip spontaneous retraction from dielectric surfaces under applied electrostatic potential

    Get PDF
    A time-resolved method for tip’ retraction at µs-scale away from dielectric surfaces has been developed. Analysis of the forces in the system comprising AFM tip, water meniscus, and polymer film suggests that an electrostatic repulsion of the tip from the surface in the double-layered (water and polymer) system, and water condensation in the tip–surface junction are the dominant factors enabling the mechanical work for tip retraction. Nanostructures of 5–80nm height are formed in polymeric surfaces as a result. This interesting physical phenomenon could be used for nanostructures patterning in polymeric materials at enhanced aspect ratio

    Atomic force microscope tip spontaneous retraction from dielectric surfaces under applied electrostatic potential

    No full text
    A time-resolved method for tip\u27 retraction at micros-scale away from dielectric surfaces has been developed. Analysis of the forces in the system comprising AFM tip, water meniscus, and polymer film suggests that an electrostatic repulsion of the tip from the surface in the double-layered (water and polymer) system, and water condensation in the tip-surface junction are the dominant factors enabling the mechanical work for tip retraction. Nanostructures of 5-80 nm height are formed in polymeric surfaces as a result. This interesting physical phenomenon could be used for nanostructures patterning in polymeric materials at enhanced aspect ratio

    The prevalence of microalbuminuria and relevant cardiovascular risk factors in Turkish hypertensive patients

    No full text
    PubMed ID: 22257801Objectives: A growing body of data illustrates the importance of microalbuminuria (MAU) as a strong predictor of cardiovascular risk in the hypertensive population. The present study was designed to define the prevalence of MAU and associated cardiovascular risk factors among Turkish hypertensive outpatients. Study design: Representing the Turkish arm of the multinational i-SEARCH study involving 1,750 sites in 26 countries around the world, a total of 1,926 hypertensive patients from different centers were included in this observational and cross-sectional survey study. Patients with reasons for a false-positive MAU test were excluded. The prevalence of MAU was assessed using a dipstick test, and patients were inquired about comorbidities, comedication, and known cardiovascular risk factors. Results: The overall prevalence of MAU was 64.7% and there was no difference between genders. Most of the patients (82.5%) had uncontrolled hypertension, 35.6% had dyslipidemia, and 35.5% had diabetes, predominantly type 2. Almost one-third of the patients (26.4%) had at least one cardiovascular-related comorbidity, with 20.3% having documented coronary artery disease (CAD). Almost all patients (96.8%) had one or more risk factors for cardiovascular disease in addition to hypertension, including family history of myocardial infarction or CAD, diabetes, dyslipidemia, lack of physical exercise, and smoking. A trend towards higher MAU values in the presence of CAD was determined. Conclusion: Microalbuminuria tests should be routinely used as a screening and monitoring tool for the assessment of subsequent cardiovascular morbidity and mortality among hypertensive patients. © 2011 Turkish Society of Cardiology

    The relationship between neutrophil/lymphocyte ratio and the TIMI flow grade in patients with STEMI undergoing primary PCI

    No full text
    OBJECTIVES: ST segment elevation myocardial infarction (STEMI) is an important cause of the morbidity and mortality in coronary artery disease. The aim of this study is to investigate the relationship between hematologic parameters and post primary PCI coronary no-reflow
    corecore